Hedge Fund - OrbiMed Advisors
Alexion Pharmaceuticals Inc. (ALXN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $183.75 |
| 2 | 2021 - Q2 (2021-06-30) | $27,722,000 | 0.28% | 150,900 | $171.66 |
| 3 | 2021 - Q1 (2021-03-31) | $15,612,000 | 0.14% | 102,100 | $154.69 |
| 4 | 2020 - Q4 (2020-12-31) | $26,405,000 | 0.23% | 169,000 | $128.50 |
| 5 | 2020 - Q3 (2020-09-30) | $249,972,000 | 3.14% | 2,184,500 | $107.88 |
| 6 | 2020 - Q2 (2020-06-30) | $241,989,000 | 3.4% | 2,156,000 | $106.17 |
| 7 | 2020 - Q1 (2020-03-31) | $185,990,000 | 3.12% | 2,071,385 | $98.14 |
| 8 | 2019 - Q4 (2019-12-31) | $179,809,000 | 2.56% | 1,662,585 | $106.96 |
| 9 | 2019 - Q3 (2019-09-30) | $162,902,000 | 3.09% | 1,663,285 | $112.72 |
| 10 | 2019 - Q2 (2019-06-30) | $252,279,000 | 3.9% | 1,926,085 | $128.89 |
| 11 | 2019 - Q1 (2019-03-31) | $264,574,000 | 4.09% | 1,957,200 | $124.34 |
| 12 | 2018 - Q4 (2018-12-31) | $199,335,000 | 3.68% | 2,047,400 | $118.20 |
| 13 | 2018 - Q3 (2018-09-30) | $400,502,000 | 4.82% | 2,881,103 | $125.44 |
| 14 | 2018 - Q2 (2018-06-30) | $387,919,000 | 4.62% | 3,124,603 | $116.87 |
| 15 | 2018 - Q1 (2018-03-31) | $364,282,000 | 4.51% | 3,268,275 | $119.53 |
| 16 | 2017 - Q4 (2017-12-31) | $344,368,000 | 4.35% | 2,879,575 | $121.78 |
| 17 | 2017 - Q3 (2017-09-30) | $511,425,000 | 4.88% | 3,645,486 | $135.86 |
| 18 | 2017 - Q2 (2017-06-30) | $471,080,000 | 4.93% | 3,871,786 | $116.39 |
| 19 | 2017 - Q1 (2017-03-31) | $449,920,000 | 5.09% | 3,710,986 | $128.92 |
| 20 | 2016 - Q4 (2016-12-31) | $414,569,000 | 5.28% | 3,388,386 | $122.36 |
| 21 | 2016 - Q3 (2016-09-30) | $323,262,000 | 3.68% | 2,638,011 | $128.72 |
| 22 | 2016 - Q2 (2016-06-30) | $348,110,000 | 3.63% | 2,981,411 | $141.88 |
| 23 | 2016 - Q1 (2016-03-31) | $260,425,000 | 2.74% | 1,870,600 | $146.83 |
| 24 | 2015 - Q4 (2015-12-31) | $433,975,000 | 3.92% | 2,275,100 | $174.68 |
| 25 | 2015 - Q3 (2015-09-30) | $348,218,000 | 3.51% | 2,226,600 | $182.41 |
| 26 | 2015 - Q2 (2015-06-30) | $369,566,000 | 3.08% | 2,044,400 | $172.57 |
| 27 | 2015 - Q1 (2015-03-31) | $98,036,000 | 0.83% | 565,700 | $181.01 |
| 28 | 2014 - Q4 (2014-12-31) | $61,430,000 | 0.58% | 332,000 | $185.30 |
| 29 | 2014 - Q3 (2014-09-30) | $51,736,000 | 0.54% | 312,000 | $164.22 |
| 30 | 2014 - Q2 (2014-06-30) | $48,750,000 | 0.57% | 312,000 | $157.90 |
| 31 | 2014 - Q1 (2014-03-31) | $40,619,000 | 0.49% | 267,000 | $159.01 |
| 32 | 2013 - Q4 (2013-12-31) | $30,949,000 | 0.45% | 232,900 | $120.01 |
| 33 | 2013 - Q3 (2013-09-30) | $25,079,000 | 0.44% | 215,900 | $109.71 |
| 34 | 2012 - Q3 (2012-09-30) | $24,424,000 | 0.7% | 213,500 | $105.51 |
| 35 | 2012 - Q1 (2012-03-31) | $20,011,000 | 0.59% | 215,500 | $81.97 |
| 36 | 2011 - Q4 (2011-12-31) | $15,637,000 | 0.51% | 218,700 | $66.35 |
| 37 | 2011 - Q3 (2011-09-30) | $14,106,000 | 0.52% | 220,200 | $55.86 |
| 38 | 2011 - Q2 (2011-06-30) | $8,061,000 | 0.14% | 171,400 | $47.95 |
| 39 | 2011 - Q1 (2011-03-31) | $6,019,000 | 0.2% | 122,000 | $45.18 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
2.0000:1.0000 on 2011-05-23